Micron Technology Achieves 1 Trillion Market Cap Milestone Amid AIDriven Memory Demand AI Industry Emerges as Key Beneficiary in MuskAltman Trial Revealing Sector Dynamics Estate Planning Dilemma Can Family Cash Out CDs of Father in Hospice Care Indias SEBI Proposes EquityLike Norms for Debt Market Plans Tokenised Bond Pilot Prediction Market Platforms Face Legal Offensive from Multiple States and Federal Regulators Gold and Silver Prices Decline as Precious Metals Face Selling Pressure QTTB Q1 2026 Earnings EPS Beat Amid Clinical Progress Stock Declines on Cash Concerns DRMA Q1 2026 Earnings NarrowerthanExpected Loss Marks Progress for ClinicalStage Biotech Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher CNTB Q1 2026 Earnings WiderthanExpected Loss as Development Pipeline Advances Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises PWP Q1 2026 Earnings EPS Misses Estimates by 6931 as Stock Declines Axsome Therapeutics AXSM Edges Lower Maintains Posture Above NearTerm Support Guggenheim Strategic Opportunities Fund GOF Edges Lower Amid Steady Trading Key Levels in Focus Carvana CVNA Surges 274 as Shares Approach Key Resistance at 7366 Ribbon Acquisition Corp Rights RIBBR Holds at 02 as Flat Trading Continues Elauwit Connection ELWT Rallies 612 as Buyers Test Key Resistance at 801 Retail Traders Outperform Professionals on Prediction Markets NYT Analysis Finds EVGO Q1 2026 Earnings Narrower Loss Surpasses Analyst Expectations Amidst Operational Gains Bluemount Holdings Limited BMHL Rises Modestly as Key Support Holds Black Spade Acquisition III BIII Holds Steady Near 10 as SPAC Awaits Business Combination H World Group HTHT Retreats 337 Amid Sector Pressure Support Levels in Focus AN2 Therapeutics ANTX Slides 27 as Shares Test Support Near 427 NWPX Infrastructure Inc NWPX Pushes Higher as Infrastructure Demand Strengthens SoYoung SY Slips 68 as Support Test Looms KALA Bio Dips 65 Support Test Looms as Biotech Faces Pressure Silexion Therapeutics Corp Warrant SLXNW Faces Continued Selling Pressure at Penny Level